BE868173A - Nouveaux hexahydro-1-hydroxy-9-hydroxymethyl-6h-dibenzo-(b,d)pyranes substitues en position 3, leur procede de preparation et composition pharmaceutique les contenant - Google Patents

Nouveaux hexahydro-1-hydroxy-9-hydroxymethyl-6h-dibenzo-(b,d)pyranes substitues en position 3, leur procede de preparation et composition pharmaceutique les contenant

Info

Publication number
BE868173A
BE868173A BE188609A BE188609A BE868173A BE 868173 A BE868173 A BE 868173A BE 188609 A BE188609 A BE 188609A BE 188609 A BE188609 A BE 188609A BE 868173 A BE868173 A BE 868173A
Authority
BE
Belgium
Prior art keywords
pyranes
dibenzo
hydroxymethyl
hydroxy
substituted
Prior art date
Application number
BE188609A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE868173A publication Critical patent/BE868173A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
BE188609A 1977-06-17 1978-06-16 Nouveaux hexahydro-1-hydroxy-9-hydroxymethyl-6h-dibenzo-(b,d)pyranes substitues en position 3, leur procede de preparation et composition pharmaceutique les contenant BE868173A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/807,439 US4133819A (en) 1977-06-17 1977-06-17 Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US06/024,783 US4232018A (en) 1977-06-17 1979-03-29 Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents

Publications (1)

Publication Number Publication Date
BE868173A true BE868173A (fr) 1978-12-18

Family

ID=26698861

Family Applications (1)

Application Number Title Priority Date Filing Date
BE188609A BE868173A (fr) 1977-06-17 1978-06-16 Nouveaux hexahydro-1-hydroxy-9-hydroxymethyl-6h-dibenzo-(b,d)pyranes substitues en position 3, leur procede de preparation et composition pharmaceutique les contenant

Country Status (8)

Country Link
US (2) US4133819A (fr)
JP (2) JPS549274A (fr)
BE (1) BE868173A (fr)
DE (1) DE2826849A1 (fr)
FR (1) FR2394541A1 (fr)
GB (2) GB2004553B (fr)
LU (1) LU79824A1 (fr)
NL (1) NL7806509A (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
US4327028A (en) * 1978-08-17 1982-04-27 Calcol, Inc. Composition of matter
US4454144A (en) * 1982-06-21 1984-06-12 Pfizer Inc. Substituted dibenzo[b,d]pyran analgesics
JPS6086601U (ja) * 1983-11-21 1985-06-14 株式会社トキメック パイロツト形シヨツクレス切換弁
IL80411A (en) * 1986-10-24 1991-08-16 Raphael Mechoulam Preparation of dibenzopyranol derivatives and pharmaceutical compositions containing them
JPH0192519U (fr) * 1987-12-11 1989-06-16
US5521215A (en) * 1989-11-07 1996-05-28 Ramot University Authority For Applied Research And Industrial Development Ltd. NMDA-blocking pharmaceuticals
US5284867A (en) * 1989-11-07 1994-02-08 Yissum Research Development Company Of The Hebrew University In Jerusalem NMDA-blocking pharmaceutical compositions
IL92238A (en) * 1989-11-07 1995-07-31 Yissum Res Dev Co ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation
US6096740A (en) * 1990-11-06 2000-08-01 Ramot University Authority For Applied Research And Industrial Development Ltd. Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions
IL101927A0 (en) * 1992-05-19 1992-12-30 Yissum Res Dev Co Probe for cannabinoid receptors
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
GB2394894B (en) * 2002-11-04 2005-08-31 G W Pharma Ltd New use for pharmaceutical composition
CA2789262C (fr) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Systeme pharma-informatique
EP2063905B1 (fr) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Traitement des troubles hépatiques par l'administration de conjugués de protéine associée au récepteur (rap)
DK2176208T3 (en) * 2007-07-30 2015-04-27 Zynerba Pharmaceuticals Inc Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN110996926A (zh) 2017-07-20 2020-04-10 耶路撒冷希伯来大学伊萨姆研究开发有限公司 用于将亲脂性化合物递送进入和/或穿过皮肤的药物膜组合物
WO2019049145A1 (fr) 2017-09-11 2019-03-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions et procédés pour l'administration nasale de médicaments en direction du cerveau et en vue d'un effet systémique
CA3116187A1 (fr) 2017-11-29 2019-06-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions de cannabinoides et methodes
US20220008354A1 (en) 2018-11-04 2022-01-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Orally administrable cannabinoids-containing compositions and methods
WO2020263975A1 (fr) 2019-06-24 2020-12-30 Diverse Biotech, Inc. Molécules conjuguées de bêta-lactame-cannabinoïde

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
JPS5518709B2 (fr) * 1970-02-13 1980-05-21
CH558792A (de) * 1971-10-14 1975-02-14 Petrzilka Theodor Verfahren zur herstellung von tetrahydrodibenzopyranen.
US3927036A (en) * 1972-05-25 1975-12-16 Abbott Lab Basic carbonates and carbamates of benzopyrans
US3901926A (en) * 1973-04-02 1975-08-26 Abbott Lab Alkylphenyl benzopyrans
US4049653A (en) * 1973-04-05 1977-09-20 Abbott Laboratories Heterocyclic esters of alkylphenyl benzopyrans
US3968125A (en) * 1973-11-05 1976-07-06 Eli Lilly And Company Dihydroxyhexahydrodibenzo[b,d]pyrans
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor

Also Published As

Publication number Publication date
JPS549274A (en) 1979-01-24
LU79824A1 (fr) 1980-01-22
GB2004553B (en) 1982-01-06
JPS5513270A (en) 1980-01-30
FR2394541B1 (fr) 1980-10-24
FR2394541A1 (fr) 1979-01-12
NL7806509A (nl) 1978-12-19
GB2004553A (en) 1979-04-04
GB2000131B (en) 1982-01-13
GB2000131A (en) 1979-01-04
US4232018A (en) 1980-11-04
DE2826849A1 (de) 1978-12-21
US4133819A (en) 1979-01-09

Similar Documents

Publication Publication Date Title
BE868173A (fr) Nouveaux hexahydro-1-hydroxy-9-hydroxymethyl-6h-dibenzo-(b,d)pyranes substitues en position 3, leur procede de preparation et composition pharmaceutique les contenant
FR2518095B1 (fr) Nouveaux l-oxa-, thia- et aza-spirocyclo-benzene-acetamides et benzamides, leur procede de preparation et composition pharmaceutique les contenant
BE862107A (fr) Nouveaux derives de 1,4-dihydropyridine substitues en position 2, leur procede de preparation et medicament les contenant
BE885269A (fr) Nouveaux tensio-actifs non ioniques, leur procede de preparation et composition les contenant
FR2495154B1 (fr) 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant
FR2353530A1 (fr) Nouveaux derives de guanidine, leur procede de preparation et composition pharmaceutique les contenant
BE861964A (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
BE824742A (fr) Nouveaux composes d'indole substitues en positions 1 et 2, leur procede de preparation et les preparations pharmaceutiques les contenant
BE885268A (fr) Nouveaux n-propionyl-sarcosine-anilides, procede pour leur preparation et medicaments les contenant
FR2338936A1 (fr) Nouvelles 1,2-benzisothiazolinones-3, leur procede de preparation et medicament les contenant
BE858269A (fr) Nouvelles aminoalkylidenamino-1,4-dihydropyridines, leur procede de preparation et medicament les contenant
BE885156A (fr) Psoralenes, leur procede de preparation et compositions pharmaceutiques les contenant
BE864862A (fr) Nouveaux benzylidene camphres, leur procede de preparation et compositions cosmetiques les contenant
FR2333496A2 (fr) Nouveaux derives d'ethanolamine, leur procede de preparation et composition pharmaceutique les contenant
FR2351118A1 (fr) Nouveaux composes heterocycliques, leur procede de preparation et composition herbicide les contenant
BE867249A (fr) Nouveaux trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido (4,3-b) indoles, leur procede de preparation et composition pharmaceutique les contenant
FR2313928A1 (fr) Nouveaux derives pyrazoliques substitues en position 1, leur procede de preparation et medicament les contenant
FR2286643A1 (fr) Nouveaux triiodocarbanilates, leur procede de preparation et composition pharmaceutique les contenant
BE884620A (fr) Nouveaux derives d'halovincamone, leur procede de preparation et medicaments les contenant
BE884083A (fr) Nouveaux oxime-ethers, leur procede de preparation et compositions pharmaceutiques les contenant
BE865735A (fr) NOUVEAUX DERIVES DE LA PYRIDO-(2,3-b)BENZOTHIAZEPINE-(1,5)SUBSTITUES EN POSITION 5, LEUR PROCEDE DE PREPARATION ET LEUR APPLICATION PHARMACEUTIQUE
FR2303559A1 (fr) Nouveaux derives d'histidine, leur procede de preparation et composition pharmaceutique les contenant
BE867858A (fr) Nouveaux 9-hydroxexahydrodibenzo 3, pyranes leurs derives substitues en position , 1 leur procede de preparation et medicamant les contenant
FR2313927A1 (fr) Nouveaux derives pyrazoliques substitues en position 4, leur procede de preparation et composition pharmaceutique les contenant
FR2468598B1 (fr) Thiazolidones-4 substituees en 2, leur procede de preparation et les medicaments les contenant